Tag: cancer cells

July 20, 2018

Weekly Round-Up: Scythian Drops Latin America Holdings

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: MiMedx Group Leads

MiMedx Group, Avid Bioservices, Lifevantage, EyePoint Pharmaceuticals, and BioLife Solutions were last week's top gainers on the NASDAQ Biotechnology Index.
July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
July 13, 2018

Weekly Round-Up: New Deal Splits Hiku-WeedMD Merger

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
July 1, 2018

5 Top Weekly NASDAQ Biotech Stocks: Avid Bioservices on Top

Avid Bioservices, Arbutus Biopharma, Catalyst, ArQule and CTI BioPharma were last week's top gainers on the NASDAQ Biotechnology Index.
June 29, 2018

Cannabis Weekly Round-Up: Manitoba Awards New Supply Agreements

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 15, 2018

Cannabis Weekly Round-Up: The Amendment Fight for Bill C-45

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
June 10, 2018

5 Top Weekly NASDAQ Biotech Stocks: MEI Pharma on Top

MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
June 1, 2018

Cannabis Weekly Round-Up: Lift Cannabis Expo Takes Charge

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.